409 related articles for article (PubMed ID: 23489848)
1. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
Millanta F; Caneschi V; Ressel L; Citi S; Poli A
J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical vascular factor expression in canine inflammatory mammary carcinoma.
Camacho L; Peña L; Gil AG; Martín-Ruiz A; Dunner S; Illera JC
Vet Pathol; 2014 Jul; 51(4):737-48. PubMed ID: 24048323
[TBL] [Abstract][Full Text] [Related]
4. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer.
Queiroga FL; Pires I; Parente M; Gregório H; Lopes CS
Vet J; 2011 Jul; 189(1):77-82. PubMed ID: 20675158
[TBL] [Abstract][Full Text] [Related]
5. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
Clemente M; Pérez-Alenza MD; Illera JC; Peña L
Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772
[TBL] [Abstract][Full Text] [Related]
6. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
7. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
[TBL] [Abstract][Full Text] [Related]
8. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
[TBL] [Abstract][Full Text] [Related]
9. High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study.
Carvalho MI; Pires I; Prada J; Raposo TP; Gregório H; Lobo L; Queiroga FL
Vet Comp Oncol; 2017 Jun; 15(2):619-631. PubMed ID: 26792550
[TBL] [Abstract][Full Text] [Related]
10. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
11. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
12. Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer.
Alonso-Diez A; Affolter VK; Sevane N; Dunner S; Valdivia G; Clemente M; De Andrés PJ; Illera JC; Pérez-Alenza MD; Peña L
Res Vet Sci; 2022 Dec; 152():307-313. PubMed ID: 36084372
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis.
Mohammed RA; Green A; El-Shikh S; Paish EC; Ellis IO; Martin SG
Br J Cancer; 2007 Apr; 96(7):1092-100. PubMed ID: 17353919
[TBL] [Abstract][Full Text] [Related]
16. Profile of Steroid Receptors and Increased Aromatase Immunoexpression in Canine Inflammatory Mammary Cancer as a Potential Therapeutic Target.
De Andrés PJ; Cáceres S; Clemente M; Pérez-Alenza MD; Illera JC; Peña L
Reprod Domest Anim; 2016 Apr; 51(2):269-75. PubMed ID: 26899138
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
18. Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours.
Raposo TP; Pires I; Carvalho MI; Prada J; Argyle DJ; Queiroga FL
Vet Comp Oncol; 2015 Dec; 13(4):464-74. PubMed ID: 24119241
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]